Insidervault
Android app
LIVE FROM THE DATABASETRANSACTIONS 723,642COMPANIES 6,572LATEST TRADE Oct 27UPDATED Oct 28, 07:15 AM
Reporting ownerCIK 0001699022

Douglas F. Kling

52 transactions in one company, from January 2, 2025 to July 16, 2025.

Transactions
521 company
Bought · P
$0open market
Sold · S
$4.0Mopen market
Net
−$4.0Mnet selling

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
NewAmsterdam Pharma Co N.V.NAMS52—$4.0M

All transactions

52 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValueHeld after
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVJul 16MPLANOption exercise51,043$0.00—?162,702derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVJul 15MPLANOption exercise47,569$0.00—?213,745derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJul 16SPLAN51,043$21.10$1.1M44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJul 16MPLANOption exercise51,043$10.90$556K95,043
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJul 15SPLAN3,544$22.12$78K44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJul 15SPLAN44,025$21.38$941K47,544
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJul 15MPLANOption exercise47,569$10.90$519K91,569
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVJun 16MPLANOption exercise21,899$0.00—?261,314derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVJun 16MPLANOption exercise78,101$0.00—?372,829derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJun 16SPLAN18,109$19.75$358K44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJun 16SPLAN81,891$19.19$1.6M62,109
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJun 16MPLANOption exercise21,899$10.90$239K144,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJun 16MPLANOption exercise78,101$10.00$781K122,101
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVMay 15MPLANOption exercise100,000$0.00—?450,930derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOMay 15SPLAN100,000——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOMay 15MPLANOption exercise100,000$10.00$1.0M144,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVApr 15MPLANOption exercise100,000$0.00—?550,930derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOApr 15SPLAN910——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOApr 15SPLAN99,090——44,910
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOApr 15MPLANOption exercise100,000$10.00$1.0M144,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVMar 26MOption exercise16,539——0derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVMar 26AAward16,539——16,539derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOMar 26S16,539——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOMar 26MOption exercise16,539$0.00—60,539
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVMar 17MPLANOption exercise11,888$0.00—?650,930derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVMar 17MPLANOption exercise88,112$0.00—?47,251derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOMar 17SPLAN100,000——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOMar 17MPLANOption exercise11,888$10.00$119K144,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOMar 17MPLANOption exercise88,112——132,112
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVFeb 19MPLANOption exercise9,218$0.00—?126,145derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVFeb 18MPLANOption exercise90,782$0.00—?135,363derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOFeb 19SPLAN9,218——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOFeb 19MPLANOption exercise9,218——53,218
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOFeb 18SPLAN90,782——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOFeb 18MPLANOption exercise90,782——134,782
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVJan 30MPLANOption exercise13,578$0.00—?226,145derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVJan 29MPLANOption exercise56,863$0.00—?239,723derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 30SPLAN8,914——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 30SPLAN4,664——52,914
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 30MPLANOption exercise13,578——57,578
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 29SPLAN56,863——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 29MPLANOption exercise56,863——100,863
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVJan 28MPLANOption exercise25,385$0.00—?296,586derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVJan 27MPLANOption exercise104,174$0.00—?321,971derivatives
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 28SPLAN5,148——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 28SPLAN20,237——49,148
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 28MPLANOption exercise25,385——69,385
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 27SPLAN23,815——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 27SPLAN80,359——67,815
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 27MPLANOption exercise104,174——148,174
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOOJan 7AAward44,000——44,000
NewAmsterdam Pharma Co N.V.NAMSDouglas F. KlingCOODERIVJan 2AAward250,000$0.00—?250,000derivatives